The phase III results of Weinreich et al. comparing two doses of REGN-COV with placebo in 4,057 outpatients were published in medRxiv on 21 May 2021 (doi: 10.1101/2021.05.19.21257469).
These results are currently under review and an updated recommendation will be included in a future version of the guideline.
Ends.